{"id":"NCT02294461","sponsor":"Astellas Pharma Inc","briefTitle":"An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants","officialTitle":"Asian Multinational Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Oral Enzalutamide in Chemotherapy Naïve Subjects With Progressive Metastatic Prostate Cancer Who Have Failed Androgen Deprivation Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-04-23","primaryCompletion":"2015-09-20","completion":"2024-07-17","firstPosted":"2014-11-19","resultsPosted":"2017-04-12","lastUpdate":"2025-08-01"},"enrollment":395,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Progressive Metastatic Prostate Cancer"],"interventions":[{"type":"DRUG","name":"Enzalutamide","otherNames":["Xtandi","MDV3100"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Enzalutamide","type":"EXPERIMENTAL"},{"label":"Placebo","type":"EXPERIMENTAL"},{"label":"Placebo followed by Enzalutamide","type":"EXPERIMENTAL"}],"summary":"Purpose of the study was to assess the effect of enzalutamide on time to Prostate Specific Antigen (PSA) progression as compared to placebo in chemotherapy naïve participants with progressive metastatic prostate cancer who have failed androgen deprivation therapy.","primaryOutcome":{"measure":"Time to Prostate-specific Antigen (PSA) Progression","timeFrame":"From the date of randomization to PSA progression median follow-up time is 6.47 months for enzalutamide and 2.99 months for placebo","effectByArm":[{"arm":"Enzalutamide","deltaMin":8.31,"sd":null},{"arm":"Placebo","deltaMin":2.86,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":47,"countries":["China","Hong Kong","South Korea","Taiwan"]},"refs":{"pmids":["35397772"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":87,"n":202},"commonTop":["Decreased appetite","Back pain","Anaemia","Fatigue","Constipation"]}}